Abstract:In the pathway of anticancer drug development, we designed and synthesized a novel series of 6-((1 H -1,2,3-triazol-4-yl)methyl)-1,2,3,4,4a,11a-hexahydro-6 H -indolo[2,3- b ]quinoxalines 13-20 through a simple multi-step protocol starting from Isatin. Initially, 6 H -indolo[2,3- b ]quinoxaline ( 3 ) was prepared by the condensation of isatin ( 1 ) with o-cyclohexyldiamine ( 2 ) then the obtained product was reacted with propargyl bromide resulting in the formation of N -propargyl derivatives 4 . The latter compound was subjected to cycloaddition with a series of substituted aromatic azides 5-12 in the presence of copper (I) as catalyst to give the target molecules 13-20 . The structure of the newly clicked 1,2,3-triazole-1,2,3,4,4a,11a-hexahydro-6 H -indolo[2,3- b ]quinoxalines 13-20 was confirmed on the basis of their elemental analysis and spectral data. Moreover, these compounds are screened against selected human cancerous cell lines: hepatocellular carcinoma (Hep-G2), breast cancer (MCF-7) and colon cancer (HCT116) relative to healthy noncancerous control skin fibroblast cells (BJ-1) to evaluate their cytotoxic effect. All the compounds showed superior cytotoxic activities against HepG2 while, compounds 15 and 18 exhibited significant in vitro activity against MCF-7 and HCT116, respectively. In addition, compound 15 was found to fit in the ATP binding pocket during docking experiments combined with molecular dynamic simulation. Lastly, we conducted a Petra/Osiris/Molinspiration (POM) study on the recently synthesized compound. The most promising candidates were identified by evaluating primary in silico parameters, which showed considerable differences among individual synthesized compounds. These features can promote future drug candidate designing to produce better derivatives in the search for the anticancer agents, particularly those with favorable ADME parameters, low toxicity, anticipated bioactivity, and bright futures.

Design and Click Synthesis of Novel 1- Substituted-4-(3,4-Dimethoxyphenyl)-1H-1,2,3-Triazole Hybrids for Anticancer Evaluation and Molecular Docking

New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Rational design of 1,2,3-triazole hybrid structures as novel anticancer agents: synthesis, biological evaluation and molecular docking studies

Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents

Click synthesis of novel 6-((1 H -1,2,3-triazol-4-yl)methyl)-6 H -indolo[2,3- b ]quinoxalines for in vitro anticancer evaluation and docking studies

Click chemistry-based synthesis of new 1,2,3-triazolo-benzoquinoline-3-carbonitriles: anticancer screening and DFT studies

Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4H‐Chromene‐7‐Azaindole‐1,2,3‐Triazole Hybrids

Click synthesis, anticancer and molecular docking evaluation of some hexahydro-6 H -indolo[2,3- b ]quinoxalines incorporated triazole moiety

Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation, in silico studies, molecular docking, molecular dynamics simulations, and ADMET profiling

Copper(I)-Catalyzed Regioselective Synthesis of 1,2,3-Triazole–Phthalazine-1,4-dione Hybrids, and Their Anticancer and Molecular Docking Studies

Targeted synthesis via the structure-activity relationship: Biological evaluation of new 1,2,3-triazoles monoterpene as antitumor agents

Design And Synthesis Of Novel Thiazole Linked Tetrahydropyridine Analogues As Anticancer Agents

Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives

Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents

Design, Synthesis, Computational Docking and Biological Evaluation of Novel 4-Chloro-1,3-Benzoxazole Derivatives as Anticancer Agents

Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents

Novel Coumarin‐Pyrazole‐Thiazoles Hybrids: Synthesis, Anticancer Activity, Molecular Docking and In Silico ADMET prediction Studies

Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study